Strategy. Systems. Impact.
Clinical and regulatory judgement for healthtech decisions that matter
Foxdown Clinical Advisory helps early-stage healthtech companies and healthtech investors make better clinical, regulatory and governance decisions before they become expensive problems.
We work with founders, funds and angel investors who need senior clinical judgement on product direction, intended use, clinical safety, regulatory positioning, NHS readiness, evidence strategy and investor-facing clinical credibility.
Clinical, regulatory and governance advisory for healthtech founders and investors
FoundersInvestorsUK / NHS Readiness
Who we help
- Early-stage healthtech founders
- Healthtech investors
- International companies entering the UK
What we help with
- Clinical product direction
- Investor readiness
- Regulatory positioning
- UK/NHS readiness
- Clinical safety and governance
Services and Pricing
| Founder and Company Services | From |
|---|---|
| Clinical & Regulatory Positioning Review | From £3,000 |
| Pre-Raise Clinical Readiness Review | From £3,500 |
| Clinical Safety Foundation Pack | From £4,000 |
| UK/NHS Market Readiness Review | From £5,000 |
| Clinical Governance Setup | From £8,000 |
| Investor Services | From |
|---|---|
| Clinical & Regulatory Risk Screen | From £2,500 |
| Clinical & Regulatory Diligence Memo | From £5,000 UK / $8,000 US |
| Fund or Syndicate Advisory Retainer | From £2,500/month UK / $5,000/month US |
Pricing is indicative. Final scope is agreed after intake.
How We Work
- 1Intake
- 2Conflict and fit check
- 3Fixed-scope proposal
- 4Document review and analysis
- 5Written output
Why Foxdown Clinical Advisory
- Senior clinical background
- Hands-on healthtech startup experience
- UK and US market exposure
- Product, governance and regulatory judgement
- Clear written outputs for founders and investors
Example Questions We Help Answer
- Is our intended use clear enough?
- Are our clinical claims supportable?
- What would an investor worry about clinically or regulatorily?
- What clinical safety foundations do we need before deployment?
- What should we address before approaching NHS customers?
- What are the clinical risks in this investment opportunity?